Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state in which AD has minimal impact on the patient’s life by achieving pre-agreed disease control goals through the use of an appropriate systemic therapy. Prof. Dr. med. Schmid-Grendelmeier gave a practice-oriented overview of the MDA concept in his presentation.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Acute myeloid leukemia
Treatment decisions between MRD monitoring, transplantation and CAR-T cells
- Psoriasis and metabolic comorbidities: new study data
GLP-1RAs showed a valuable dual benefit
- Heart failure: combination of four as "Guideline-Directed Medical Therapy"
Standard established at HFrEF with individual nuances
- Chronic inflammation as a driver of ageing
Immunosenescence and inflammaging
- Evidence, limitations and practical implications
Phytotherapy for anxiety disorders
- Case report: Hiccups after ketoacidosis
Nebulized lidocaine brings relief
- Hidradenitis suppurativa: biologics reduce inflammatory processes
Treatment recommendations depend on the severity and inflammatory activity
- Dizziness as a leading symptom: new consensus paper